A heart failure diagnosis may sound frightening, but with the right treatment, heart failure can be controlled. Once you are on a stable medical regimen, you can often return to a full and enjoyable life. With the recent passing of actress and icon, Elizabeth Taylor, we would like to take some time to provide some information about congestive heart failure.
- Congestive Heart Failure (CHF) affects nearly 5 million Americans
- Approximately 550,000 new cases are diagnosed in the U.S. each year.
- Congestive heart failure affects people of all ages, from children and young adults to the middle-aged and the elderly.
- Almost 1.4 million persons with CHF are under 60 years of age.
- CHF is present in 2 percent of persons age 40 to 59.
- More than 5 percent of persons age 60 to 69 have CHF.
- CHF annual incidence approaches 10 per 1,000 population after 65 years of age.
- The incidence of CHF is equally frequent in men and women, and African-Americans are 1.5 times more likely to develop heart failure than Caucasians.
- More than half of those who develop CHF die within 5 years of diagnosis.
- Shortness of breath with little exertion
- Feeling weak or tired after little activity or exertion
- Difficulty sleeping due to breathing problems
- A new or different cough, especially while lying flat
- A swollen and/or tender abdomen
- Loss of appetite
- Increased urination at night
- Swelling of the feet and legs
Early diagnosis and treatment for heart failure is very important. Heart failure is a chronic condition that may follow a varied and unpredictable course. If you are experiencing heart failure symptoms, you should see your cardiologist. If you have been diagnosed with heart failure, adhering to the treatment plan designed by your doctors and nurses can help you navigate this challenge. Your symptoms can be controlled with proper medical care.
About Sonjoy Laskar, MD:
Dr. Laskar joined Emory Healthcare in 2005 and has devoted his career to providing direct care to patients with heart failure, heart transplantation and ventricular assist devices, as well as to teaching residents and fellows. He is an active researcher in the areas of echocardiography and ventricular assist devices as destination therapy, and is a member of the American College of Cardiology, Heart Failure Society of America and the International Society of Heart and Lung Transplantation